AstraZeneca Pharma India Limited
ASTRAZEN
Quarterly results
standaloneRevenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Jun 2026683
Quarter ₹ crore YoY Jun 2024 388 +31.2% Sept 2024 408 +31.2% Dec 2024 440 +44.0% Mar 2025 480 +25.4% Jun 2025 526 +35.8% Sept 2025 559 +37.0% Dec 2025 612 +38.9% Mar 2026 579 +20.4% Jun 2026 683 +29.7% - ₹ crore
Jun 20269
Quarter ₹ crore Jun 2024 8 Sept 2024 8 Dec 2024 8 Mar 2025 16 Jun 2025 11 Sept 2025 6 Dec 2025 5 Mar 2026 6 Jun 2026 9 - ₹ crore
Jun 2026692
Quarter ₹ crore Jun 2024 396 Sept 2024 416 Dec 2024 448 Mar 2025 497 Jun 2025 538 Sept 2025 565 Dec 2025 617 Mar 2026 585 Jun 2026 692 - Cost structure
- ₹ crore
Jun 202679
Quarter ₹ crore Jun 2024 61 Sept 2024 68 Dec 2024 62 Mar 2025 66 Jun 2025 64 Sept 2025 60 Dec 2025 94 Mar 2026 46 Jun 2026 79 - ₹ crore
Jun 2026641
Quarter ₹ crore Jun 2024 353 Sept 2024 365 Dec 2024 373 Mar 2025 412 Jun 2025 462 Sept 2025 487 Dec 2025 572 Mar 2026 525 Jun 2026 641 - Exceptional items and tax
- ₹ crore
Jun 202651
Quarter ₹ crore Jun 2024 -15 Sept 2024 51 Dec 2024 42 Mar 2025 78 Jun 2025 75 Sept 2025 73 Dec 2025 47 Mar 2026 58 Jun 2026 51 - ₹ crore
Jun 202613
Quarter ₹ crore Jun 2024 -3 Sept 2024 13 Dec 2024 11 Mar 2025 20 Jun 2025 19 Sept 2025 19 Dec 2025 14 Mar 2026 13 Jun 2026 13 - Profit
- ₹ crore
Jun 202638
Quarter ₹ crore YoY Jun 2024 -12 -121.9% Sept 2024 38 -26.6% Dec 2024 31 +95.2% Mar 2025 58 +47.6% Jun 2025 56 +573.6%* Sept 2025 54 +41.1% Dec 2025 33 +5.6% Mar 2026 45 -23.0% Jun 2026 38 -32.1% - Per share
- ₹ per share
Jun 202615.17
Quarter ₹ per share Jun 2024 -4.72 Sept 2024 15.37 Dec 2024 12.34 Mar 2025 23.30 Jun 2025 22.33 Sept 2025 21.69 Dec 2025 13.04 Mar 2026 17.95 Jun 2026 15.17
| ₹ crore | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 388 | 408 | 440 | 480 | 526 | 559 | 612 | 579 | 683 | |
| Revenue YoY | +31.2% | +31.2% | +44.0% | +25.4% | +35.8% | +37.0% | +38.9% | +20.4% | +29.7% |
| 8 | 8 | 8 | 16 | 11 | 6 | 5 | 6 | 9 | |
| 396 | 416 | 448 | 497 | 538 | 565 | 617 | 585 | 692 | |
| Cost structure | |||||||||
| 61 | 68 | 62 | 66 | 64 | 60 | 94 | 46 | 79 | |
| 353 | 365 | 373 | 412 | 462 | 487 | 572 | 525 | 641 | |
| Exceptional items and tax | |||||||||
| -15 | 51 | 42 | 78 | 75 | 73 | 47 | 58 | 51 | |
| -3 | 13 | 11 | 20 | 19 | 19 | 14 | 13 | 13 | |
| Profit | |||||||||
| -12 | 38 | 31 | 58 | 56 | 54 | 33 | 45 | 38 | |
| Net profit YoY | -121.9% | -26.6% | +95.2% | +47.6% | +573.6%* | +41.1% | +5.6% | -23.0% | -32.1% |
| Per share | |||||||||
| -4.72 | 15.37 | 12.34 | 23.30 | 22.33 | 21.69 | 13.04 | 17.95 | 15.17 | |
Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.